financetom
Business
financetom
/
Business
/
Bentley Systems Insider Sold Shares Worth $557,270, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bentley Systems Insider Sold Shares Worth $557,270, According to a Recent SEC Filing
May 26, 2025 5:25 AM

04:27 PM EDT, 05/09/2025 (MT Newswires) -- Brock Ballard, Chief Revenue Officer, on May 07, 2025, sold 12,363 shares in Bentley Systems ( BSY ) for $557,270. Following the Form 4 filing with the SEC, Ballard has control over a total of 68,064 Class B common shares of the company, with 68,064 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1031308/000110465925046733/xslF345X05/tm2512769-8_4seq1.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Fuji Soft Inc: Board Decided To Recommend Shareholders To Tender Shares To KKR-Backed Group's First Tender Offer
BRIEF-Fuji Soft Inc: Board Decided To Recommend Shareholders To Tender Shares To KKR-Backed Group's First Tender Offer
Sep 26, 2024
Sept 26 (Reuters) - Fuji Soft Inc: * FUJI SOFT INC - BOARD DECIDED TO RECOMMEND SHAREHOLDERS TO TENDER SHARES TO KKR-BACKED GROUP'S FIRST TENDER OFFER * FUJI SOFT INC - BOARD REMAINS UNDECIDED ABOUT WHETHER TO RECOMMEND KKR-BACKED GROUP'S SECOND TENDER OFFER Source text for Eikon: Further company coverage: ...
Alnylam Pharma Confident in ATTR-CM Treatment's Market Potential, Cautious on Regulatory Risks, RBC Says
Alnylam Pharma Confident in ATTR-CM Treatment's Market Potential, Cautious on Regulatory Risks, RBC Says
Sep 26, 2024
03:43 PM EDT, 09/19/2024 (MT Newswires) -- Alnylam Pharmaceuticals ( ALNY ) is very confident regarding a commercial uptake of its transthyretin amyloid cardiomyopathy, or ATTR-CM, treatment but remains cautious about regulatory challenges, RBC Capital Markets said in a Thursday note. On regulatory, language was a bit more guarded (mgmt did not definitively rule out the possibility of an AdCom)...
Evotec, Novo Nordisk Partner on Cell Therapies
Evotec, Novo Nordisk Partner on Cell Therapies
Sep 26, 2024
06:01 AM EDT, 09/26/2024 (MT Newswires) -- Evotec (EVO) and Novo Nordisk ( NVO ) said Thursday they are partnering to develop off-the-shelf cell therapies for possible commercialization. Financial terms of the deal were not disclosed. Under the agreement, Novo Nordisk ( NVO ) will provide funding for Evotec's research and development site in Gottingen, Germany, and its cell therapy...
ING Comments on The Euro
ING Comments on The Euro
Sep 26, 2024
06:01 AM EDT, 09/26/2024 (MT Newswires) -- The support from China's stimulus story waned on Wednesday and EUR/USD's exploration above 1.1200 proved to be very short-lived amid quarter-end US dollar (USD) buying, said ING. Investors will likely see a bit more range-bound swings around the 1.110-1.120 area in the near term unless United States data offers clearer direction to markets,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved